Neurodegenerative consequences of PanK2 mutations
PanK2 突变的神经退行性后果
基本信息
- 批准号:7216264
- 负责人:
- 金额:$ 17.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-15 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:4&apos-phosphopantetheineAcetyl Coenzyme AActive SitesAcyl Carrier ProteinAgeAllosteric RegulationAlzheimer&aposs DiseaseAntibodiesAntioxidantsBasal GangliaBehavioralBiochemicalBiochemistryBiological AssayBrainBrain regionCell Culture SystemCell FractionationCell LineCell physiologyCellsCessation of lifeCharacteristicsCitric Acid CycleCoenzyme ACognitionComplexCritical PathwaysCultured CellsDiseaseDisruptionDoctor of PhilosophyEnvironmental Risk FactorEnzymesEstersFatty AcidsFrameshift MutationFunctional disorderGene MutationGene TargetingGenerationsGenesGeneticGlobus PallidusGoalsHalf-LifeHumanHuman Cell LineHydrogen PeroxideImpairmentIn VitroIronKnock-outKnockout MiceLabelLeadLinkLocalizedLysineLysophospholipidsMediatingMetabolismMitochondriaMouse Cell LineMovementMovement DisordersMusMutationNerve DegenerationNeurodegenerative DisordersNeurogliaNeurologistNeuronsNonsense CodonNumbersOxidative StressPalmitoyl Coenzyme APantothenate kinaseParkinson DiseasePathogenesisPathologicPatternPhosphorylationPhysiologic pulsePlasmid Cloning VectorPoint MutationPopulationPredispositionPrevalenceProcessProductionPropertyProsthesisProteinsProteolytic ProcessingPulse takingPyruvate Dehydrogenase ComplexRadioRadiolabeledRecombinant ProteinsRecombinantsRegulationResearchResearch Project GrantsResistanceRoleScientistSmall Interfering RNASocietiesSpeechStaining methodStainsStructureSubstantia nigra structureSystemThioctic AcidVitaminsWorkcell injurycofactorcostembryonic stem cellexperiencehomologous recombinationinhibitor/antagonistinsightmotor deficitmutantneuron lossnull mutationpantothenateprotein functionradiotracerresearch studyresponseskillssynucleinuptake
项目摘要
DESCRIPTION (provided by applicant): The candidate is an M.D./Ph.D neurologist who is currently a trainee in the Center for Neurodegenerative Disease Research. His goal is to develop additional research skills and experience needed to become an independent clinician scientist working to understand the pathogenesis of neurodegenerative diseases. The proposed research project focuses on neurodegeneration with brain iron accumulation (NBIA), which causes progressive impairment of speech, movement and cognition. At the neuropathological level, NBIA is characterized by iron accumulation, inclusion formation, signs of oxidative stress, and death of multiple neuronal populations. These features are also seen to varying degrees in other neurodegenerative diseases, including Parkinson's disease and Alzheimer's disease. Mutations in the gene for pantothenate kinase 2 (PanK2) were recently identified in a subset of NBIA cases. The PanK2 gene encodes an enzyme involved in coenzyme A (CoA) synthesis, a critical pathway linked to a number of cellular processes, including fatty acid synthesis, energy production, and possibly, synthesis of anti-oxidant molecules. The long term objectives of this project are to understand how PanK2 mutations lead to iron accumulation, oxidative stress, inclusion formation, and neuronal death. The proteolytic processing, mitochondrial localization and in vitro catalytic properties will by characterized for mutant Pank2 proteins and compared to the wild type human PanK2 protein. Cell culture systems will be established in which PanK2 expression is eliminated and in which wild type or mutant PanK2 proteins are over-expressed. Mice that lack PanK2 expression will also be generated. Cell lines and mice lacking PanK2 expression will be examined for changes in levels of biochemical intermediates hypothesized to be dependent on PanK2 function. Finally, neuronal and non-neuronal cells lacking PanK2 will be examined for signs of increased oxidative stress, susceptibility to oxidative injury, cellular and mitochondrial import of radio labeled iron, and inclusion formation.
描述(由申请人提供):候选人是M.D./PH.D神经科医生,目前是神经退行性疾病研究中心的实习生。他的目标是发展额外的研究技能和经验,成为一名独立的临床医生,旨在了解神经退行性疾病的发病机理。拟议的研究项目侧重于脑铁的积累(NBIA),这会导致语音,运动和认知的逐渐损害。在神经病理学水平上,NBIA的特征是铁的积累,纳入形成,氧化应激的迹象以及多个神经元种群的死亡。这些特征在其他神经退行性疾病(包括帕金森氏病和阿尔茨海默氏病)中也有所不同。在NBIA病例的一部分中,最近发现了泛素激酶2(PANK2)的基因突变。 PANK2基因编码参与辅酶A(COA)合成的酶,这是与许多细胞过程相关的关键途径,包括脂肪酸合成,能量产生,可能是抗氧化剂分子的合成。该项目的长期目标是了解Pank2突变如何导致铁的积累,氧化应激,包容形成和神经元死亡。蛋白水解加工,线粒体定位和体外催化特性将以突变型Pank2蛋白的特征,并与野生型人Pank2蛋白进行比较。将建立消除PANK2表达的细胞培养系统,并在其中野生型或突变体Pank2蛋白过度表达。缺乏pank2表达的小鼠也将产生。将检查缺乏PANK2表达的细胞系和小鼠,以了解假设依赖PANK2功能的生化中间体水平的变化。最后,将检查缺乏PANK2的神经元和非神经元细胞,以了解氧化应激增加,氧化损伤的易感性,无线电标记的铁的细胞和线粒体进口的易感性以及纳入形成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL T KOTZBAUER其他文献
PAUL T KOTZBAUER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL T KOTZBAUER', 18)}}的其他基金
Imaging Ligands for Alpha-Synuclein Fibril Accumulation in Multiple System Atrophy
多系统萎缩中α-突触核蛋白原纤维积累的成像配体
- 批准号:
10452228 - 财政年份:2022
- 资助金额:
$ 17.6万 - 项目类别:
Imaging Ligands for Alpha-Synuclein Fibril Accumulation in Multiple System Atrophy
多系统萎缩中α-突触核蛋白原纤维积累的成像配体
- 批准号:
10581664 - 财政年份:2022
- 资助金额:
$ 17.6万 - 项目类别:
IDENTIFICATION OF FLUORESCENT LIGANDS FOR ALPHA SYNUCLEIN FIBRILS
α 突触核蛋白原纤维荧光配体的鉴定
- 批准号:
9789973 - 财政年份:2018
- 资助金额:
$ 17.6万 - 项目类别:
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA
路易体痴呆中α-突触核蛋白的结构生物学
- 批准号:
10246509 - 财政年份:2018
- 资助金额:
$ 17.6万 - 项目类别:
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA
路易体痴呆中α-突触核蛋白的结构生物学
- 批准号:
10473717 - 财政年份:2018
- 资助金额:
$ 17.6万 - 项目类别:
Structural Biology of Alpha-Synuclein in Lewy Body Dementia
路易体痴呆中α-突触核蛋白的结构生物学
- 批准号:
10729722 - 财政年份:2018
- 资助金额:
$ 17.6万 - 项目类别:
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA
路易体痴呆中α-突触核蛋白的结构生物学
- 批准号:
10023948 - 财政年份:2018
- 资助金额:
$ 17.6万 - 项目类别:
相似国自然基金
磷酸化c-Jun/SPDEF轴在ROS1阳性肺癌靶向治疗耐药中的作用及机制研究
- 批准号:82304516
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Mps1磷酸化RPA2增强ATR介导的DNA损伤修复促进高级别浆液性卵巢癌PARP抑制剂耐药的机制研究
- 批准号:82303896
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CAFs中GPBAR1促进肝外胆管癌FGFR2磷酸化和培米替尼耐药的分子机制
- 批准号:82303324
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多组学研究STAT3调控CKMT2和CD36-FABP4影响脂肪细胞参与乳腺癌细胞磷酸肌酸合成的耐药代谢重编程
- 批准号:82360604
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
GPI介导磷酸戊糖途径的分流促进NF-κB信号通路激活--胶质瘤干细胞化疗耐药新机制?
- 批准号:82303874
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A phase 2 study of a vitamin metabolite for PKAN
PKAN 维生素代谢物的 2 期研究
- 批准号:
10683049 - 财政年份:2019
- 资助金额:
$ 17.6万 - 项目类别:
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
靶向半胱氨酸输入诱导胰腺癌铁死亡细胞
- 批准号:
10590731 - 财政年份:2017
- 资助金额:
$ 17.6万 - 项目类别:
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
靶向半胱氨酸输入诱导胰腺癌铁死亡细胞
- 批准号:
10446758 - 财政年份:2017
- 资助金额:
$ 17.6万 - 项目类别: